Zoekresultaten - 1 result
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
antibodies than people vaccinated with a vector-borne vaccine (AstraZeneca, Johnson&Johnson). In the not vaccinated population, people with a blood type O are less likely to have anti- SARS-CoV‑2 ...